(Q44701900)

5 December 2017

1 reference

title

Drug interactions. Mechanisms and clinical relevance (English)

1 reference

5 December 2017

U Klotz

1

1 reference

5 December 2017

W Beil

2

1 reference

5 December 2017

C Gleiter

3

1 reference

5 December 2017

B Drewelow

4

1 reference

5 December 2017

E Garbe

5

1 reference

5 December 2017

A Gillessen

6

1 reference

5 December 2017

E Mutschler

7

1 reference

5 December 2017

language of work or name

German

0 references

publication date

1 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

44

1 reference

5 December 2017

11

1 reference

5 December 2017

1444-1449

1 reference

Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.

5 December 2017

1 reference

12 December 2020

P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin

1 reference

12 December 2020

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

1 reference

12 December 2020

Drug-drug interactions among elderly patients hospitalized for drug toxicity

1 reference

12 December 2020

Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture

1 reference

12 December 2020

Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms

1 reference

12 December 2020

Omeprazole treatment does not affect the metabolism of caffeine

1 reference

12 December 2020

Drug interactions at the renal level. Implications for drug development

1 reference

12 December 2020

Effect of omeprazole on the pharmacokinetics of itraconazole

1 reference

12 December 2020

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

1 reference

12 December 2020

Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions

1 reference

12 December 2020

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Increased drug delivery to the brain by P-glycoprotein inhibition

1 reference

12 December 2020

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

12 December 2020

Acute heart transplant rejection due to Saint John's wort

1 reference

12 December 2020

Drug interaction of St John's wort with cyclosporin

1 reference

12 December 2020

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

12 December 2020

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

1 reference

12 December 2020

Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin

1 reference

12 December 2020

Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline

1 reference

12 December 2020

Effect of St John's wort on the pharmacokinetics of fexofenadine

1 reference

12 December 2020

Drug metabolism and drug interactions in the elderly

1 reference

12 December 2020

BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.

1 reference

12 December 2020

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

1 reference

12 December 2020

Changes in plasma protein binding have little clinical relevance

1 reference

12 December 2020

Mammalian ABC transporters in health and disease

1 reference

12 December 2020

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]

1 reference

12 December 2020

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

1 reference

12 December 2020

Potential drug-drug interactions in the medication of medical patients at hospital discharge

1 reference

12 December 2020

Specific and dose-dependent enzyme induction by omeprazole in human beings.

1 reference

12 December 2020

10.1007/S00108-003-1045-Y

Identifiers

DOI

1 reference

release_nzmgcwygdbgtxpcwruo6a6zeoi

5 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nzmgcwygdbgtxpcwruo6a6zeoi

24 November 2022

mapped directly with Wikidata item

1 reference